十一月 2025
- Home
- Rossari Biotech
十一月 2025的Rossari Biotech市场份额分析
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries.
显示 Rossari Biotech 主网站(包括公司地区网站)的流量和参与度信息
查看更多网站流量和参与度信息- rossari.com
- tristarintermediates.org
Rossari Biotech收入截至 十一月 2025为 200M - 500M
Rossari Biotech主要域名产生的收入
3 年中Rossari Biotech主要域名的收入
Rossari Biotech主要域名的收入
Rossari Biotech热门域名的总访问量
了解Rossari Biotech市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Rossari Biotech热门域名的平均访问时长
分析Rossari Biotech参与度指标。
过去 3 个月的平均访问时长
子公司明细
Rossari Biotech热门域名的平均页面浏览量
了解Rossari Biotech如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Rossari Biotech 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Rossari Biotech Ltd hires Sunil Nair as Chief Human Resources Officer (CHRO).Rossari Biotech Limited, a leading manufacturer of specialty chemicals, enzymes, and other products for various industries including home, personal care and performance chemicals, textiles specialty chemicals, animal health & nutrition products, is pleased to announce the appointment of Sunil Nair as the Chief Human Resources Officer (CHRO) for Rossari Biotech and its esteemed Group Companies.
五月 8, 2024阅读更多
新闻Rossari Biotech Ltd hired Esha Padmanabhan Achan as Additional Director on Oct 21st '23.Rossari Biotech Limited at the AGM, the shareholders approved the appointment of Ms. Esha Padmanabhan Achan as an Additional Director designated as Non-Executive, Independent Director with effect from October 21, 2023.
十月 21, 2023阅读更多
新闻Rossari Biotech Ltd acquired Tristar Intermediates for $2.04M on Jul 1st '21.Rossari acquired 16% of the remaining stake in Tristar Intermediates for a consideration of Rs 16.9 cr.
八月 1, 2023阅读更多
查看 Rossari Biotech 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。